SCOPOLAMINE TRANSDE

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the supply of 10,000 scopolamine transdermal patches with NSN 6505014562380 at a total contract value of $654.80. The award was issued on July 14, 2026, with delivery required on or before July 29, 2026, to the destination address at Fort Bragg, North Carolina, under FOB destination terms, meaning the contractor assumes all transportation costs and risks until delivery. The item is supplied as a single line item with no flexibility in quantity, as indicated by a zero variance tolerance. Packaging and marking instructions specify shipment must occur via the fastest traceable means and prohibit parcel post, but no specific military packaging standards or bar-coding requirements like MIL-STD-129 or UID are referenced. Inspection and acceptance are to be conducted by the government upon arrival at the destination, with no explicit quality or testing criteria outlined beyond compliance with the NSN and manufacturer identifiers. The contract is funded through a government appropriation with associated DIC, DIST, and FC codes, and payment is to be processed through a remittance address in Fort Bragg. No separate contract clauses, representations, certifications, evaluation factors, special requirements, or attachments are documented in the available materials, suggesting this is a streamlined administrative procurement for a standard pharmaceutical item under a pre-established logistics vehicle. The awardee's socioeconomic status, size certification, and any affirmative representations are not provided, and the contracting office contact information is limited to a TCN and organizational identifier without individual names or roles.